Literature DB >> 32038795

Effects of Oral Rutaecarpine on the Pharmacokinetics of Intravenous Chlorzoxazone in Rats.

Sudeep R Bista1, Sang Kyu Lee2, Dinesh Thapa1, Mi Jeong Kang1, Young Min Seo1, Ju Hyun Kim1, Dong Hyeon Kim1, Yurngdong Jahng1, Jung Ae Kim1, Tae Cheon Jeong1.   

Abstract

It has been reported that hepatic microsomal cytochrome P450 (CYP) 2E1 is responsible for the metabolism of chlorzoxazone (CZX) to 6-hydroxychlorzoxazone. The present study was undertaken to assess the possible interaction of rutaecarpine, an alkaloid originally isolated from the unripe fruit of Evodia rutaecarpa, with CZX. Male Spraque-Dawley rats were administered with 80 mg/kg/day of oral rutaecarpine for three consecutive days. Twenty four hr after the pre-treatment with rutaecarpine, the rats were treated with 20 mg/kg of intravenous CZX Rat hepatic microsomes isolated from rutaecarpine-treated rats showed greater (50% increase) activity of p-nitrophenol hydroxylase (a marker of CYP2E1) when compared with the control rats. Compared with control rats, the AUC of CZX was significantly smaller (84% decrease) possibly due to significantly faster CL (646% increase) in rats pretreated with rutaecarpine. This could be, at least partially, due to induction of CYP2E1 by rutaecarpine. © Korean Society of Toxicology 2008.

Entities:  

Keywords:  CYP2E1; Chlorzoxazone; In vivo; Interaction; Pharmacokinetics; Rutaecarpine

Year:  2008        PMID: 32038795      PMCID: PMC7006287          DOI: 10.5487/TR.2008.24.3.195

Source DB:  PubMed          Journal:  Toxicol Res        ISSN: 1976-8257


  21 in total

1.  Characterization of in vitro metabolites of rutaecarpine in rat liver microsomes using liquid chromatography/tandem mass spectrometry.

Authors:  Sang Kyu Lee; Jaeick Lee; Eung-Seok Lee; Yurngdong Jahng; Dong-Hyun Kim; Tae Cheon Jeong
Journal:  Rapid Commun Mass Spectrom       Date:  2004       Impact factor: 2.419

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  Alteration of the pharmacokinetics of theophylline by rutaecarpine, an alkaloid of the medicinal herb Evodia rutaecarpa, in rats.

Authors:  Yune-Fang Ueng; Tung-Hu Tsai; Ming-Jaw Don; Ruei-Ming Chen; Ta-Liang Chen
Journal:  J Pharm Pharmacol       Date:  2005-02       Impact factor: 3.765

4.  Effects of Evodia rutaecarpa and rutaecarpine on the pharmacokinetics of caffeine in rats.

Authors:  Tung-Hu Tsai; Chun-Hao Chang; Lie-Chwen Lin
Journal:  Planta Med       Date:  2005-07       Impact factor: 3.352

5.  Pharmacokinetics of chlorzoxazone in humans.

Authors:  R K Desiraju; N L Renzi; R K Nayak; K T Ng
Journal:  J Pharm Sci       Date:  1983-09       Impact factor: 3.534

6.  General derivation of the equation for time to reach a certain fraction of steady state.

Authors:  D Perrier; M Gibaldi
Journal:  J Pharm Sci       Date:  1982-04       Impact factor: 3.534

7.  Critical evaluation of the potential error in pharmacokinetic studies of using the linear trapezoidal rule method for the calculation of the area under the plasma level--time curve.

Authors:  W L Chiou
Journal:  J Pharmacokinet Biopharm       Date:  1978-12

8.  A new class of COX-2 inhibitor, rutaecarpine from Evodia rutaecarpa.

Authors:  T C Moon; M Murakami; I Kudo; K H Son; H P Kim; S S Kang; H W Chang
Journal:  Inflamm Res       Date:  1999-12       Impact factor: 4.575

9.  Effect of the acute-phase response on the pharmacokinetics of chlorzoxazone and cytochrome P-450 2E1 in vitro activity in rats.

Authors:  K Rockich; R Blouin
Journal:  Drug Metab Dispos       Date:  1999-09       Impact factor: 3.922

10.  Physiological disposition and metabolic fate of chlorzoxazone (paraflex) in man.

Authors:  A H CONNEY; J J BURNS
Journal:  J Pharmacol Exp Ther       Date:  1960-04       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.